Insider Transactions in Q1 2024 at Core Scientific, Inc. (CORZ)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Todd A Becker |
BUY
Open market or private purchase
|
Direct |
130,000
+49.2%
|
$390,000
$3.16 P/Share
|
|
Mar 15
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$300,000
$3.32 P/Share
|
|
Mar 15
2024
|
Yadin Rozov |
BUY
Open market or private purchase
|
Direct |
80,000
+50.0%
|
$240,000
$3.07 P/Share
|
|
Mar 15
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
65,300
+41.06%
|
$195,900
$3.06 P/Share
|
|
Mar 15
2024
|
Eric Stanton Weiss |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$45,000
$3.03 P/Share
|
|
Feb 22
2024
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
24,153
-5.73%
|
$72,459
$3.23 P/Share
|
|
Feb 22
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,617
-10.94%
|
$49,851
$3.23 P/Share
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,294,195
+50.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,337,169
+26.33%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,294,195
-100.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,483,592
-100.0%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
29,453,080
+25.57%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
29,111,651
-100.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
BUY
Grant, award, or other acquisition
|
Direct |
1,211,956
+50.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,211,956
-100.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,518,472
+50.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,518,472
-100.0%
|
-
|
|
Jan 23
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,453
+50.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Indirect |
21,154,604
+30.81%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,179,833
+25.21%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
20,244,350
-100.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,094,478
-100.0%
|
-
|
|
Jan 23
2024
|
Dr Kneeland Youngblood |
BUY
Grant, award, or other acquisition
|
Direct |
400,038
+50.0%
|
-
|
|
Jan 23
2024
|
Dr Kneeland Youngblood |
SELL
Sale (or disposition) back to the issuer
|
Direct |
400,038
-100.0%
|
-
|
|
Jan 23
2024
|
Todd M Duchene |
BUY
Grant, award, or other acquisition
|
Direct |
3,751,387
+25.68%
|
-
|
|
Jan 23
2024
|
Todd M Duchene |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,700,040
-100.0%
|
-
|